Recurrent cancer‐associated <scp>ERBB4</scp> mutations are transforming and confer resistance to targeted therapies
Veera K. Ojala(Åbo Akademi University), Kari J. Kurppa(Åbo Akademi University)
Cited by 0
Related Papers
The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration
|Journal of Biological Chemistry|2020|17
Pharmacokinetics and efficacy of tank-water administered BRAF-inhibitor dabrafenib in a zebrafish model of BRAF-mutant melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0
YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0